Last Updated: Wednesday, May 15, 2013
Principal Investigator: Gregory N. Barnes, M.D., Ph.D.
L-dopa has been safely and effectively used by people with Parkinson's disease for many decades. Recent understandings of brain function in people with Angelman leads us to expect that L-dopa could be beneficial in people with Angelman syndrome.
Previous studies have already determined the safety of this dosage in 4 to 12 year old children. Now we are interested in whether and how it might help them.
This study works alongside our Natural History study to evaluate the medical and psychological functioning of children with Angelman. For this study there will also be:
4 to 12 year old children with Angelman syndrome
Medical and psychological evaluations and reports
5 day long visits
Stefanie Barnett, CCRP
615-343-5750 (Mon-Wed) 615-875-4897 (Thur-Fri)
Three to seven year old children with ASD, with and without intellectual disabilityCompensation: Yes
Children with ASD and epilepsy or suspected epilepsy
who are 3 to 10 years old
with or without an intellectual disabilityCompensation: Yes
Children 4—8 years old
Diagnosed with Autism Spectrum Disorders (ASD)
Who have abnormal EEG’s without seizures (Will be confirmed in initial screening visits)Compensation: Yes
Visit this investigator's people page to list all of their studies together.